These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Patents, pills and politics: the Australia-United States Free Trade Agreement and the Pharmaceutical Benefits Scheme. Harvey K Aust Health Rev; 2004 Nov; 28(2):218-26. PubMed ID: 15527402 [TBL] [Abstract][Full Text] [Related]
4. Economic grand rounds: potential effects of the new medicare drug benefit on pricing for psychotropic medications. Huskamp HA; Shinogle JA Psychiatr Serv; 2005 Sep; 56(9):1056-8. PubMed ID: 16148317 [No Abstract] [Full Text] [Related]
5. Medicare should bargain for lower drug prices, study says. Med Health; 2005 Oct; 59(36):1, 3, 7. PubMed ID: 16240494 [No Abstract] [Full Text] [Related]
6. The need for health care reform. Mossinghoff GJ Health Syst Rev; 1994; 27(3):5-6. PubMed ID: 10134516 [No Abstract] [Full Text] [Related]
7. If foreign drug prices go up, will U.S. prices come down? Med Health; 2003 Dec; 57(45):2-4. PubMed ID: 14723168 [No Abstract] [Full Text] [Related]
9. Senate GOP tosses drug bill. Law would have let Medicare negotiate costs directly. DoBias M Mod Healthc; 2007 Apr; 37(17):12. PubMed ID: 17479495 [No Abstract] [Full Text] [Related]
10. Australia-United States Free Trade Agreement and the Australian Pharmaceutical Benefits Scheme. Sainsbury P Yale J Health Policy Law Ethics; 2004; 4(2):387-99. PubMed ID: 15536920 [No Abstract] [Full Text] [Related]
11. Probing Our Moral Values in Health Care: The Pricing of Specialty Drugs. Reinhardt U JAMA; 2015 Sep; 314(10):981-2. PubMed ID: 26348738 [No Abstract] [Full Text] [Related]
13. Prescription drug pricing: the consumer perspective. Searing A N C Med J; 2003; 64(6):300-2. PubMed ID: 14983625 [No Abstract] [Full Text] [Related]
14. Barrier to trade or barrier to profit? Why Australia's Pharmaceutical Benefits Scheme worries U.S. drug companies. Hamilton C; Lokuge B; Denniss R Yale J Health Policy Law Ethics; 2004; 4(2):373-85. PubMed ID: 15536919 [No Abstract] [Full Text] [Related]
15. Making medicines affordable: the price factor (position paper). American Public Health Association Am J Public Health; 2001 Mar; 91(3):486-90. PubMed ID: 11236429 [No Abstract] [Full Text] [Related]
16. Pharma APMs: Can the Industry Learn To Play Well With Others? Alston M; Pyenson B Manag Care; 2018 Sep; 27(9):31-32. PubMed ID: 30216160 [TBL] [Abstract][Full Text] [Related]
17. Prescription drug prices in Canada. Gross D Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 Jun; (IB62):1-22. PubMed ID: 12807123 [No Abstract] [Full Text] [Related]
18. States combat drug costs. Consum Rep; 2002 Dec; 67(12):8-9. PubMed ID: 12448442 [No Abstract] [Full Text] [Related]
19. Managed care cost containment involving prescription drugs. American Medical Association, Council on Ethical and Judicial Affairs. Food Drug Law J; 1998; 53(1):25-34. PubMed ID: 11795334 [No Abstract] [Full Text] [Related]
20. Prescription-drug coupons--no such thing as a free lunch. Ross JS; Kesselheim AS N Engl J Med; 2013 Sep; 369(13):1188-9. PubMed ID: 23984672 [No Abstract] [Full Text] [Related] [Next] [New Search]